Last Posted: Apr 09, 2020
- Association of Long Noncoding RNA Biomarkers With Clinical Immune Subtype and Prediction of Immunotherapy Response in Patients With Cancer
Y Yu et al, JAMA Network Open, April 7, 2020 - Pembrolizumab for management of patients with NSCLC and brain metastases: long-term results and biomarker analysis from a non-randomised, open-label, phase 2 trial.
Goldberg Sarah B et al. The Lancet. Oncology 2020 Apr - Feasibility of next-generation sequencing in clinical practice: results of a pilot study in the Department of Precision Medicine at the University of Campania 'Luigi Vanvitelli'.
De Falco Vincenzo et al. ESMO open 2020 Mar 5(2) - How Many Adults Are at Risk of Serious Illness If Infected with Coronavirus? Updated Data
W Koma et al, Global Health Policy, KFF, April 7, 2020 - Moving towards personalized treatments of immune-related adverse events
K Esfahani et al, Nat Rev Clin Oncology, April 3, 2020 - Landscape of Germline Mutations in DNA Repair Genes for Breast Cancer in Latin America: Opportunities for PARP-Like Inhibitors and Immunotherapy.
Urbina-Jara Laura Keren et al. Genes 2019 10(10) - Comparison of commonly used solid tumor targeted gene sequencing panels for estimating tumor mutation burden shows analytical and prognostic concordance within the cancer genome atlas cohort.
Bevins Nicholas et al. Journal for immunotherapy of cancer 2020 Mar 8(1) - Rational Discovery of Response Biomarkers: Candidate Prognostic Factors and Biomarkers for Checkpoint Inhibitor-Based Immunotherapy.
Hou Qianqian et al. Advances in experimental medicine and biology 2020 1248143-166 - A TP53 -associated gene signature for prediction of prognosis and therapeutic responses in lung squamous cell carcinoma.
Xu Feng et al. Oncoimmunology 2020 9(1) 1731943 - Management of ampullary adenomas in familial adenomatous polyposis syndrome: 16 years of experience from a tertiary cancer center.
Angsuwatcharakan Phonthep et al. Gastrointestinal endoscopy 2020 Mar
.jpg)
No hay comentarios:
Publicar un comentario